Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Simulations Plus (SLP) Stock Price
News stories about Simulations Plus (NASDAQ:SLP) have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Simulations Plus earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 45.6197795504566 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Simulations Plus (SLP) and The Competition Head to Head Review (americanbankingnews.com)
- Simulations Plus (SLP) vs. Its Competitors Head-To-Head Analysis (americanbankingnews.com)
- Tabula Rasa Healthcare (TRHC) versus Simulations Plus (SLP) Critical Review (americanbankingnews.com)
- Simulations Plus, Inc. (SLP) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com)
- Simulations Plus (SLP) and Its Rivals Critical Comparison (americanbankingnews.com)
Simulations Plus (NASDAQ:SLP) opened at 15.20 on Monday. The stock has a market cap of $262.12 million, a P/E ratio of 48.25 and a beta of -0.71. The stock has a 50 day moving average of $14.56 and a 200-day moving average of $12.70. Simulations Plus has a one year low of $8.10 and a one year high of $16.15.
Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Friday, July 14th. The technology company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.02. The business had revenue of $6.75 million during the quarter, compared to the consensus estimate of $6.48 million. Simulations Plus had a return on equity of 23.21% and a net margin of 24.86%. Analysts anticipate that Simulations Plus will post $0.32 EPS for the current year.
A number of equities analysts have recently issued reports on SLP shares. Zacks Investment Research upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating and set a $17.00 price target for the company in a report on Tuesday, July 25th. BidaskClub downgraded shares of Simulations Plus from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Simulations Plus (SLP) Stock Price” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/25/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-simulations-plus-slp-stock-price.html.
In other Simulations Plus news, CEO Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $15.07, for a total value of $278,795.00. Following the completion of the transaction, the chief executive officer now directly owns 5,684,916 shares in the company, valued at $85,671,684.12. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 36.93% of the stock is owned by company insiders.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Stock Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related stocks with our FREE daily email newsletter.